Subscribe for great stories in your community!
Plymouth Meeting’s Inovio Pharmaceuticals is getting closer to seeking U.S. Food & Drug Administration approval for its first DNA medicine, writes John George…
The biotech industry in the Philadelphia area continues to undergo some belt-tightening, but Christopher Molineaux of Life Sciences Pennsylvania says, “the pace of innovation…
CRB, a global provider of engineering, architecture, and construction solutions to life sciences and food and beverage industries, has moved its Philadelphia-area operations to…
Merck, the biggest employer in Montgomery County is fighting back against the Inflation Reduction Act in court and in Washington, writes Andrew Seidman for The…
Plymouth Meeting-based Inovio Pharmaceuticals is on the right track to launch its first product which would also be the first DNA medicine in the…
On a recent episode of Fortune’s “Leadership Next” podcast, co-host Alan Murray talked to Ken Frazier, former CEO of Merck on the importance…
Plymouth Meeting-based Harmony Biosciences Holdings has appointed Peter Anastasiou, chief executive officer of a development stage company Capsida, to the company’s board of…
Plymouth Meeting biotech company Inovio’s innovations are paying off. Amid positive feedback from the FDA on an experimental respiratory disease therapy, the Montgomery County…
Anna Maria Barry-Jester recently explored why GlaxoSmithKline has delayed a tuberculosis vaccine, an important global public health project for ProPublica.
Back in 2018, research…
Conshohocken-based Madrigal Pharmaceuticals is in a flurry of activity as it prepares for the potential launch of its NASH drug candidate, writes John George…
The University of Pennsylvania is basking in the glow of Katalin Karikó and Drew Weissman, two researchers who recently discovered they had been awarded the…
Katalin Karikó, the Abington scientist whose work led to RNA vaccines that transformed the threat of the COVID-19 pandemic, was awarded the Nobel Prize…
Gene therapy pioneer Dr. James Wilson shared his hope for the future of cell and gene therapy at Life Sciences Pennsylvania’s “Life Sciences Future…
Conshohocken-based Madrigal Pharmaceuticals plans to raise $500 million while anticipating FDA approval of a groundbreaking therapy, writes John George for the Philadelphia Business Journal…
Scorpion Capital filed a citizens petition with the U.S. Food and Drug Administration asking to have the federal agency reverse its approval of Plymouth…
Center for Breakthrough Medicines in King of Prussia sold its controlling interest to SK Pharmteco after experiencing some investing lags that led to the layoff…
Before we send you to this site, please subscribe to our daily newsletter.